doi: 10.1097/00002030-198802000-00004.
Neutralizing monoclonal antibodies to the AIDS virus
Affiliations
- PMID: 2451922
- DOI: 10.1097/00002030-198802000-00004
Item in Clipboard
Neutralizing monoclonal antibodies to the AIDS virus
AIDS.
1988 Feb.
Abstract
The production of neutralizing monoclonal antibodies (MAbs) will permit the exact localization of neutralizing epitopes on the AIDS virus, HIV-1. We describe the properties of seven MAbs to the envelope of the LAV-1 isolate. Five MAbs recognise the central portion of gp110, amino acids 279-472, and four of these are capable of high-titre neutralization of HIV-1, by infection inhibition, syncytial inhibition and vesicular stomatitis virus (VSV) pseudotype neutralization. One of the two MAbs to gp41 inhibits syncytium formation. Neutralization, live cell immunofluorescence and immunoprecipitation of gp110 are type-specific and restricted to HIV-1 isolates closely related to LAV-1.
Similar articles
-
Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide.Virology. 1988 Jul;165(1):209-15. doi: 10.1016/0042-6822(88)90674-5. Virology. 1988. PMID: 2838959
-
Monoclonal antibodies to gp110 and gp41 of human immunodeficiency virus.J Clin Microbiol. 1987 May;25(5):845-8. doi: 10.1128/jcm.25.5.845-848.1987. J Clin Microbiol. 1987. PMID: 2438302 Free PMC article.
-
Neutralizing monoclonal antibody against a external envelope glycoprotein (gp110) of SIVmac251.AIDS Res Hum Retroviruses. 1995 Apr;11(4):501-8. doi: 10.1089/aid.1995.11.501. AIDS Res Hum Retroviruses. 1995. PMID: 7632464
-
SIV neutralization epitopes.Chem Immunol. 1993;56:78-90. Chem Immunol. 1993. PMID: 7680868 Review. No abstract available.
-
Role of neutralizing antibodies in HIV infection.AIDS. 2003;17 Suppl 4:S67-71. doi: 10.1097/00002030-200317004-00008. AIDS. 2003. PMID: 15080182 Review. No abstract available.
Cited by
-
Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication.J Exp Med. 1988 Dec 1;168(6):1953-69. doi: 10.1084/jem.168.6.1953. J Exp Med. 1988. PMID: 3264318 Free PMC article.
-
Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range.J Virol. 1991 Jan;65(1):162-9. doi: 10.1128/JVI.65.1.162-169.1991. J Virol. 1991. PMID: 1845882 Free PMC article.
-
Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.J Virol. 1991 Jan;65(1):31-41. doi: 10.1128/JVI.65.1.31-41.1991. J Virol. 1991. PMID: 1985202 Free PMC article.
-
Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvant.J Virol. 1991 Jan;65(1):450-6. doi: 10.1128/JVI.65.1.450-456.1991. J Virol. 1991. PMID: 1985208 Free PMC article.
-
Analysis of the cross-reactive anti-gp120 antibody population in human immunodeficiency virus-infected asymptomatic individuals.J Virol. 1993 Feb;67(2):953-60. doi: 10.1128/JVI.67.2.953-960.1993. J Virol. 1993. PMID: 7678311 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources